尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准

智通财经2025-11-14

智通财经APP讯，尖峰集团(600668.SH)发布公告，近日，公司全资子公司浙江尖峰药业有限公司的控股子公司浙江尖峰亦恩生物科技有限公司(以下简称“尖峰亦恩”)，收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，经审查，2025年09月08日受理的JFAN-1001甲磺酸盐胶囊符合药品注册的有关要求，同意本品联合酒石酸长春瑞滨软胶囊在晚期非鳞非小细胞肺癌患者中开展临床试验。据悉，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2583452047?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-14 15:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583452047","market":"fut","top_or_hot":-1,"title":"尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准","media":"智通财经","content":"<div>\n<p>智通财经APP讯，尖峰集团(600668.SH)发布公告，近日，公司全资子公司浙江尖峰药业有限公司的控股子公司浙江尖峰亦恩生物科技有限公司(以下简称“尖峰亦恩”)，收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，经审查，2025年09月08日受理的JFAN-1001甲磺酸盐胶囊符合药品注册的有关要求，同意本品联合酒石酸长春瑞滨软胶囊在晚期非鳞非小细胞肺癌患者中开展临床试验。据悉，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1369264.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n尖峰集团(600668.SH)：JFAN-1001甲磺酸盐胶囊获得药物临床试验批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-14 15:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1369264.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，尖峰集团(600668.SH)发布公告，近日，公司全资子公司浙江尖峰药业有限公司的控股子公司浙江尖峰亦恩生物科技有限公司(以下简称“尖峰亦恩”)，收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，经审查，2025年09月08日受理的JFAN-1001甲磺酸盐胶囊符合药品注册的有关要求，同意本品联合酒石酸长春瑞滨软胶囊在晚期非鳞非小细胞肺癌患者中开展临床试验。据悉，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1369264.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1369264.html","article_id":"2583452047","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583452047","pubTimestamp":1763105980,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"据悉，JFAN-1001 甲磺酸盐胶囊是尖峰亦恩开发的抗肿瘤新药，注册分类属于化学药品1类，适应症为 EGFR-T790M 继发突变阳性的局部晚期或转移性非鳞非小细胞肺癌。尖峰亦恩JFAN-1001甲磺酸盐胶囊联合酒石酸长春瑞滨软胶囊的临床试验申请于2025年09月08日获得受理。截至目前，除本次新获得批准的临床试验外，JFAN-1001胶囊正在国内进行Ⅱ期临床试验，并已获得美国食品药品监督管理局药物临床试验许可。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600668":"尖峰集团","BK0188":"融资融券","BK0186":"小盘成长","BK0235":"非金矿物"},"translate_title":"Jianfeng Group (600668. SH): JFAN-1001 mesylate capsules obtained drug clinical trial approval","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600668":1.5},"content_text":"智通财经APP讯，尖峰集团(600668.SH)发布公告，近日，公司全资子公司浙江尖峰药业有限公司的控股子公司浙江尖峰亦恩生物科技有限公司(以下简称“尖峰亦恩”)，收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，经审查，2025年09月08日受理的JFAN-1001甲磺酸盐胶囊符合药品注册的有关要求，同意本品联合酒石酸长春瑞滨软胶囊在晚期非鳞非小细胞肺癌患者中开展临床试验。据悉，JFAN-1001 甲磺酸盐胶囊是尖峰亦恩开发的抗肿瘤新药，注册分类属于化学药品1类，适应症为 EGFR-T790M 继发突变阳性的局部晚期或转移性非鳞非小细胞肺癌。尖峰亦恩JFAN-1001甲磺酸盐胶囊联合酒石酸长春瑞滨软胶囊的临床试验申请于2025年09月08日获得受理。截至目前，除本次新获得批准的临床试验外，JFAN-1001胶囊正在国内进行Ⅱ期临床试验，并已获得美国食品药品监督管理局药物临床试验许可。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583452047","isCrawlerRequest":true}